MedImmune Has A Higher Loss In Third Quarter
70317
MedImmune Inc. reported a third-quarter loss yesterday, despite $61 million in sales of its lead product, Synagis, a 25 percent increase over the same period a year ago.
120706
Merck & Co  on Monday said its third-quarter profit rose sharply, helped by sales of its vaccines and cholesterol drugs, and raised its 2007 profit forecast in view of strong current trends.
569961
By Rosie Murray-West, City Correspondent (Filed: 01/10/2004). US pharmaceutical giant Merck lost about a quarter of its value yesterday after it pulled arthritis drug Vioxx owing to concerns over heart attacks as a side-effect.
232152
The loss, which came to $3.41 a share, was in contrast to a profit of $45.4 million, or 97 cents a share, in the quarter a year earlier.
420175
3Com Corp. COMS.O on     Thursday posted  a wider-than-expected second-quarter loss, amid stiff  competition from Cisco Systems Inc. CSCO.O and others in the  telecommunications networking market.
738503
YESTERDAY Close $54.64 Change +$1.53 52-WEEK High $55.14 Low $42.29 Merck &amp; Co., the third-largest US drug maker, reported a 63 percent increase in earnings and raised its forecast for the year after a vaccine for cervical cancer and a new pill for diabetes drove sales higher.
184473
By Deborah Cohen CHICAGO  - Telecommunications equipment makerCiena Corp.  on Thursday reported a wider loss for thefiscal third quarter due to slack demand and forecast sales inthe current quarter would be little changed from the thirdquarter.
770376
OSI Pharmaceuticals Inc. on Monday posted a wider loss for the year ended Sept. 30, hurt by greater research and development costs and one-time charges during the period.
208598
MARLBOROUGH, Mass. -- 3Com Corp. posted a narrower net loss in its latest quarter amid a sharp drop in operating expenses. For the fiscal first quarter ended Aug. 27, the maker of computer-networking equipment
254390
Losses ballooned to $207.3 million for the third quarter, driven by lower extended warranty sales and restructuring costs.
698753
MedImmune Inc.&#39;s cancellation of trials for an arthritis and psoriasis treatment sent the company&#39;s stock lower Monday and helped drag down the entire biotechnology sector.
294668
A.M.D. reported a net loss of $396 million, larger than Wall Street expected, but sales were up 23 percent on strong personal-computer demand.
72091
Sprint Corp. FON.N on Tuesday  reported a wider third-quarter loss due to a $3.5 billion  writedown in the value of its long-distance business.
203040
Medical-care ratio concerns trip up shareholders.
475502
The drug company posts a wider Q3 loss than a year ago.
429987
Opera Software, the maker of the No. 3 Web browser, reported a third-quarter net loss Friday that was more than three times greater than the year before, despite an increase in revenue.
621950
The drugstore chain said its quarterly loss narrowed as a result of an income tax benefit and increased sales of generic drugs.